Kalvista Pharmaceuticals Inc (KALV NASDAQ) stock market data APIs
$27.0012
0(0%)
as of June 12, 2026
Try our APIs with
free plan!
Kalvista Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
As of June 11, 2026, KalVista Pharmaceuticals, Inc. was taken private. KalVista Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops oral therapies for rare diseases in worldwide markets. It offers sebetralstat, a novel, oral, on-demand treatment for hereditary angioedema (HAE), and an oral Factor XIIa inhibitor program. KalVista Pharmaceuticals, Inc. was formerly known as KalVista Pharmaceuticals Ltd. and changed its name to KalVista Pharmaceuticals, Inc. in November 2016. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts. As of June 11, 2026, KalVista Pharmaceuticals, Inc. operates as a subsidiary of Chiesi Farmaceutici S.p.A.
Prev. Close
27.0012
Open
27.0012
High
27.0012
Low
27.0012
52 wk Range
9.83-27
Market Cap
1 438 M
Shares Outstanding
53 241 K
Revenue
114 M
EPS
-0.43
Beta
-0.109
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Kalvista Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Kalvista Pharmaceuticals Inc data using free add-ons & libraries
Get Kalvista Pharmaceuticals Inc Fundamental Data
Kalvista Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 114 M
- EBITDA: -138 447 008
- Earnings Per Share: -3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Kalvista Pharmaceuticals Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-04-30
- EPS/Forecast: -0.3763
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Kalvista Pharmaceuticals Inc News
New
KalVista's (KALV) Chief Development Officer Sells 33,800 Shares for $905,000
Christopher Yea, Chief Development Officer of KalVista Pharmaceuticals(NASDAQ:KALV), reported the exercise of 33,800 options into common stock and the immediate sale of those shares for a total value ...
KalVista's (KALV) Chief Development Officer Sells 33,800 Shares for $905,000
Key Points 33,800 shares were exercised and sold for a total of ~$905,000 on May 27, 2026. This transaction represented 12.82% of Yea's direct holdings prior to the trade, reducing direct ownership t...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: KalVista Pharmaceuticals, Inc. (Nasdaq – KALV), Thermon Group Holdings, Inc. (NYSE – THR), Sila Realty Trust, Inc. (NYSE – SILA), Lisata Therapeutics, Inc. (Nasdaq – LSTA)
BALA CYNWYD, Pa., May 14, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (...
Halper Sadeh LLC is Investigating Whether KALV, THR, CECO are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Sharehold...
Get Kalvista Pharmaceuticals Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
